Home
About
Services
Partners
Client Portfolio
News
Contact
Small-cap stocks shrug off debt concerns, for the moment
February 5, 2019
Fiat Chrysler recalls 882,000 pickup trucks for steering, pedal issues
February 5, 2019
0
U.S. jury orders Takeda to pay Bayer $155 million over hemophilia drug
Published by
Muller&Green
at
February 5, 2019
Categories
RSS
Tags
A U.S. jury has ordered Takeda Pharmaceutical Co’s Baxalta unit to pay Bayer AG $155.19 million for infringing a patent related to a Baxalta hemophilia treatment, court records made public on Tuesday show.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more